Begin main content

Reports

We found 4944 result(s)

An assessment of oseltamivir for the treatment of suspected influenza

Published on: April 2, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Husereau DR, Brady B, McGeer A. An assessment of oseltamivir for the treatment of suspected influenza. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology overview no 7. The Issue Annually, influenza causes significant morbidity and mortality. It is difficult to diagnose true influenza withou...

Tags

Oseltamivir, Tamiflu, Influenza, Grippe, Drug Therapy, Cost-Benefit Analysis, Influenza, Neuraminidase inhibitors, flu, Chimiothérapie, Analyse coût bénéfice, Cost-effectiveness analysis, Economic evaluation, oseltamivir Tamiflu, inhibiteurs de la neuraminidase, analyse coût-efficacité, évaluation économique

Activated protein C for severe sepsis

Published on: April 1, 2002
Result type: Reports

Summary Severe sepsis is a systemic inflammatory response to infection involving organ dysfunction. Severe sepsis is a common cause of death and is associated with a 20%1 to 56%1-5 mortality rate. Drotrecogin alpha (activated) is a recombinant human activated protein C (rhAPC) approved in the U.S. for the reduction of mortality in adult patients...

Tags

Recombinant Proteins, Severe Sepsis, APACHE II, Infection Control, Anti-Infective Agents, Infection, Inflammation, Protein C, Sepsis, Infection control, Proteines Recombinaison, drotrecogin alpha, recombinant human activated protein C, Xigris, PROWESS, septicémie grave, alpha drotrécogine (activée), protéine C activée recombinante humaine

Radiofrequency catheter ablation for cardiac arrhythmias: A clinical and economic review

Published on: April 1, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Noorani HZ, Yee R, Marshall D, Connolly S, Nichol G, O'Brien B. Radiofrequency catheter ablation for cardiac arrhythmias: a clinical and economic review. Ottawa: Canadian Coordinating Office for Health Technology Assessment. 2002. Technology report no 25. The Issue Catheter ablation is a procedure intended for the treatment of patients ...

Tags

Arrhythmia, Catheter Ablation, Wolff-Parkinson-White Syndrome, Pre-Excitation Syndromes, Atrial Flutter, Tachycardia, Radiofrequency Catheter Ablation, Cardiac Arrhythmias, Tachycardia, Paroxysmal, Tachycardia, Supraventricular, Cardiovascular, Arrhythima - economics, Catheter Ablation - economics, Paroxysmal, Supraventricular, paroxysmal supraventricular tachycardia, focal atrial tachycardias, re-entrant atrial tachycardias, Ablation, Arythmie, Ablation par cathéter, Arythmie ? économie, Ablation par cathéter-économie, Syndrome de Wolff-Parkinson-White, Syndromes de pré-excitation, Flutter auriculaire, Tachycardie, paroxystique, supraventriculaire, ablation par cathéter faisant appel à la radiofréquence, arythmies cardiaques, tachycardie paroxystique supraventriculaire, tachycardies auriculaires focales, tachycardies auriculaires par réentrée

Computer-enhanced surgical systems (“robotic surgery”)

Published on: March 27, 2002
Result type: Reports

Summary Computer-linked surgical systems allow surgeons to perform procedures without coming into contact with the patient. Indications for these robotic surgery systems are expanding. This technology offers potential advantages through enabling more precise surgery, which may lead to shorter patient recovery times, fewer complications and impro...

Tags

Robotics, Telemedicine, Laparoscopy, Coronary Artery Bypass, Mitral Valve, Thoracoscopy, Equipment and Supplies, Costs and Cost Analysis, Technology Assessment, Telerobotics, Computer-Assisted Surgery, Bicuspid Valve, Pleuroscopy, Surgical Procedures, Minimally Invasive, Surgery, Medical devices, Surgical Procedures, Minimally Invasive, Computer- Assisted, Biomedical, da Vinci Surgical System, Zeus Robotic Surgical System, EndoAssist, Robotic surgery, Minimally-invasive surgery, Minimally-invasive surgical procedures, Coronary Bypass, Medical equipment, Health technology assessment, HTA, Système chirurgical da Vinci, Système chirurgical robotique Zeus, Chirurgie robotique, Télérobotique, Chirurgie à effraction minimale, Interventions chirurgicales à effraction minimale, Chirurgie assistée par ordinateur

Infliximab for the treatment of Crohn’s disease: A systematic review and cost-utility analysis

Published on: March 25, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Marshall J, Blackhouse G, Goeree R, Brazier N, Irvine E, Faulkner L, Dipchand C, O'Brien B. Infliximab for the Treatment of Crohn's Disease: A Systematic Review and Cost-Utility Analysis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology report no 24. The Issue Crohn's disease (CD) is a chr...

Tags

Gastrointestinal Agents, Antibodies, Crohn Disease, Drug Therapy, Cost-Benefit Analysis, Quality of Life, Decision Support Techniques, Decision Analysis, Decision Modeling, QALY, Gastrointestinal Tract, Antibodies, Monoclonal, Gastrointestinal tract, crohns, Crohn’s, Monoclonal, Cost-Utility Analysis, Remicade, Infliximab, Cost-effectiveness, Economic evaluation, QALYs, Models, Decision Support, Agents gastrointestinaux, Anticorps monoclonal, Crohn, Maladie, Chimiothérapie, Analyse coût bénéfice, Qualité vie, Systèmes aide décision, infliximab, rapport coût-efficacité, évaluation économique, analyse décisionnelle, modèle décisionnel, modélisation, aide à la décision, anti-tnf, ibd, inflammatory bowel disease

Extracorporeal immunoadsorption treatment for rheumatoid arthritis

Published on: March 15, 2002
Result type: Reports

Summary Immunoadsorption treatment is a non-drug therapy for rheumatoid arthritis. The treatment is based on filtering the patient's plasma through a column containing staphylococcal protein A. The treatment is effective in alleviating the symptoms of severe rheumatoid arthritis in some patients. Data on long-term outcomes are not available. The...

Tags

Arthritis, Immunosorbent Techniques, Plasmapheresis, Staphylococcal Protein A, Costs and Cost Analysis, Equipment and Supplies, Device Approval, Medical Device, Arthritis, Rheumatoid, Arthritis, Medical devices, Rheumatoid, Prosorba Column, Immunoadsorption techniques, Medical equipment, Regulatory status, Colonne Prosorba, Techniques d’immunoadsorption, Appareil médical, Dispositifs médicaux, Réglementation

The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis

Published on: February 22, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Maetzel A, Krahn M, Naglie G. The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology report no 23. The Issue Nonsteroidal anti-inflammatory drugs (NSAIDs) are core therapeutics in the manag...

Tags

Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Osteoarthritis, Arthritis, Drug Therapy, Risk Factors, Cost-Benefit Analysis, Quality of Life, Decision Support Techniques, Cyclooxygenase 2, NSAIDs, Rheumatoid Arthritis, Decision Analysis, Decision Modeling, QALY, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Rheumatoid, Arthritis, Non-Steroidal, Rheumatoid, Gastrointestinal System, Cost-Utility Analysis, Celecoxib, Rofecoxib, COX2, Gastrointestinal Effects, Cost-effectiveness, Economic evaluation, QALYs, Models, Decision Support, célécoxib, rofécoxib, cyclo-oxygénase 2, Coxib, AINS, Arthrite rhumatoïde, Effets gastrointestinaux, Coût-efficacité, Évaluation économique, Analyse décisionnelle, Modèle décisionnel, Modélisation, appui décisionnel, Célécoxib, Rofécoxib, COX-2

Emerging Drug List — Tiotropium bromide

Published on: February 20, 2002
Result type: Reports
Product Line: Emerging Drug List

Tags

Pulmonary Disease, COPD, Chronic Obstructive Lung Disease, Scopolamine, Muscarinic Antagonists, Antimuscarinic Agents, Muscarinic Receptors, Bronchodilator Agents, Bronchodilators, Cholinergic Antagonists, Anticholinergic Agents, Drug Therapy, Drug Approval, Drugs, Investigational Drugs, Lung, Receptors, Muscarinic, Pulmonary Disease, Chronic Obstructive, COPD, Respiratory, Spiriva, Bronchopneumopathie, Tiotropium bromide, Chronic Obstructive, Derives, Antagonistes muscariniques, Receptors, Muscarinic, Récepteur muscarinique, Bronchodilatateurs, Antagonistes cholinergiques, Scopolamine Derivatives Scopolamine, Dérivés, Chimiothérapie, Autorisation mise sur marché médicament, Regulatory status, Investigational, Médicament phase recherche, Spiriva, Bromure de tiotropium, BPCO, Antimuscarinique, Bronchodilatateur, Anticholinergique, Réglementation, Médicaments expérimentaux

Emerging Drug List — Etonogestrel/ethinyl estradiol

Published on: February 19, 2002
Result type: Reports
Product Line: Emerging Drug List

Tags

Contraceptive Devices, Female, Contraceptives, Ethinyl Estradiol, Vinyl Compounds, Drug Approval, Drugs, Oral Contraceptives, Estrogen Analogs, Investigational Drugs, Contraceptive Devices, Female, Contraceptives, Oral, Synthetic, Medical devices, Gynecology/obstetrics, Oral, Synthetic, l’oestrogène Synthetic, Investigational, NuvaRing, Composés vinyliques, Composés vinyl, Regulatory status, Dispositif contraceptif, Contraceptif oral, Analogue de l’oestrogène, Composés, vinyliques, Réglementation, Médicaments expérimentauxl’oestrogène Synthetic, Médicaments expérimentaux,

Tension-free vaginal tape (TVT) for urinary incontinence

Published on: February 19, 2002
Result type: Reports
Product Line: Preassessments

Tags

Urinary Incontinence, Equipment and Supplies, Costs and Cost Analysis, Technology Assessment, Tension-Free Vaginal Tape, Medical devices, Kidney/urologic, Biomedical, TVT, Transvaginal tape, Stress incontinence, Medical equipment, Health technology assessment, HTA, bandelette vaginale sans tension, bandelette transvaginale, incontinence urinaire d’effort, équipement médical, appareil médical